B4GALNT3 Antibody (Center) Blocking peptide

Background:
B4GALNT3 transfers N-acetylgalactosamine (GalNAc) ontoglucosyl residues to form N,N-prime-diacetyllactosediamine(LacdiNAc, or LDN), a unique terminal structure of cell surfaceN-glycans (Ikehara et al., 2006 [PubMed 16728562]).[supplied byOMIM].

Other Names:
Beta-1,4-N-acetylgalactosaminyltransferase 3, B4GalNAcT3, Beta4GalNAc-T3, Beta4GalNAcT3, Beta-1,4-N-acetylgalactosaminyltransferase III, N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2, NGalNAc-T2, B4GALNT3

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13658c was selected from the Center region of B4GALNT3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: B4GALNT3

Gene ID: 283358
Primary Accession: Q6L9W6
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.